MedPath

ZYPREXA VELOTAB 5 MG COMPRIMIDOS BUCODISPERSABLES

ZYPREXA VELOTAB 5 MG COMPRIMIDOS BUCODISPERSABLES

Commercialized
Register Number

99125001IP4

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jan 22, 2024

Dosage Form

COMPRIMIDO BUCODISPERSABLE

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number99125001IP4
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

OLANZAPINAActive
Quantity: 5 mg
Name: OLANZAPINA

ATC CLASSIFICATION (3)

N05A
N05AH
N05AH03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.